Becton Dickinson PE Ratio 2006-2018 | BDX

Current and historical p/e ratio for Becton Dickinson (BDX) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Becton Dickinson PE ratio as of October 19, 2018 is 22.81.
Becton Dickinson PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-10-19 238.09 102.63
2018-06-30 239.56 $2.32 103.26
2018-03-31 216.00 $-0.46 0.00
2017-12-31 212.65 $1.31 162.33
2017-09-30 193.99 $4.65 41.72
2017-06-30 192.46 $3.50 54.99
2017-03-31 180.26 $6.05 29.80
2016-12-31 162.04 $6.03 26.87
2016-09-30 175.14 $4.51 38.83
2016-06-30 164.65 $5.26 31.30
2016-03-31 146.82 $3.75 39.15
2015-12-31 148.35 $3.27 45.37
2015-09-30 127.18 $3.41 37.29
2015-06-30 135.19 $4.10 32.97
2015-03-31 136.46 $5.46 24.99
2014-12-31 131.70 $5.83 22.59
2014-09-30 107.25 $6.00 17.87
2014-06-30 110.96 $4.93 22.51
2014-03-31 109.31 $4.80 22.77
2013-12-31 102.68 $4.74 21.66
2013-09-30 92.48 $6.50 14.23
2013-06-30 90.93 $7.47 12.17
2013-03-31 87.52 $7.54 11.61
2012-12-31 71.17 $7.54 9.44
2012-09-30 71.05 $5.62 12.64
2012-06-30 67.21 $5.55 12.11
2012-03-31 69.39 $5.49 12.64
2011-12-31 66.37 $5.48 12.11
2011-09-30 64.73 $5.63 11.50
2011-06-30 75.69 $5.95 12.72
2011-03-31 69.60 $5.71 12.19
2010-12-31 73.50 $5.57 13.20
2010-09-30 64.12 $5.51 11.64
2010-06-30 58.20 $5.12 11.37
2010-03-31 67.40 $5.22 12.91
2009-12-31 67.20 $5.04 13.33
2009-09-30 59.15 $5.00 11.83
2009-06-30 60.19 $4.83 12.46
2009-03-31 56.48 $4.62 12.23
2008-12-31 57.15 $4.65 12.29
2008-09-30 66.72 $4.46 14.96
2008-06-30 67.36 $4.33 15.56
2008-03-31 70.89 $4.11 17.25
2007-12-31 68.79 $3.97 17.33
2007-09-30 67.31 $3.46 19.45
2007-06-30 60.92 $3.15 19.34
2007-03-31 62.67 $3.00 20.89
2006-12-31 56.98 $2.65 21.50
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $63.704B $12.093B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $26.448B 10.12
Align Technology (ALGN) United States $25.123B 66.98
AmerisourceBergen (ABC) United States $20.078B 14.59
Laboratory Of America Holdings (LH) United States $17.588B 16.18
Cardinal Health (CAH) United States $15.950B 11.08
Henry Schein (HSIC) United States $12.633B 21.54
Cooper (COO) United States $12.492B 22.50
West Pharmaceutical Services (WST) United States $8.366B 43.26
DENTSPLY SIRONA (XRAY) United States $8.067B 14.12
Merit Medical Systems (MMSI) United States $3.433B 45.12
Patterson (PDCO) United States $2.220B 15.60
CONMED (CNMD) United States $2.017B 34.16
STAAR Surgical (STAA) United States $1.782B 238.47
Atrion (ATRI) United States $1.278B 37.87
Antares Pharma (ATRS) United States $0.526B 0.00
Invacare (IVC) United States $0.471B 0.00
Lifevantage (LFVN) United States $0.145B 20.56
Endologix (ELGX) United States $0.134B 0.00
Aceto (ACET) United States $0.066B 43.00
Pro-Dex (PDEX) United States $0.041B 25.70
Biolase (BIOL) United States $0.027B 0.00